BNP And NTproBNP Market Report 2026

BNP And NTproBNP Market Overview

• BNP And NTproBNP market size has reached to $2.26 billion in 2025 • Expected to grow to $4.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Aging Population Drives BNP and NTproBNP Market Growth • Market Trend: Rapid Screening Bioassays Shaping The BNP and NTproBNP Market Landscape • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under BNP And NTproBNP Market?

A BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) tests refer to a test that measures the amount of BNP or its prohormone NT-proBNP in the bloodstream, detecting heart failure and other heart-related ailments. BNP, or NT-proBNP, are natriuretic peptides that play a crucial role in regulating circulation. The high levels of BNP or NT-proBNP are indications of underlying heart disease (abnormality in pumping blood). The main types of BNP and NTproBNP are BNP (brain natriuretic peptide) and NT-proBNP (N-terminal pro-B-type natriuretic peptide). A BNP (B-type natriuretic peptide) test refers to a test that measures the amount of BNP in the bloodstream, detecting heart failure and other heart-related ailments. The location of testing includes point-of-care testing and laboratory testing for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), and others.

What Is The BNP And NTproBNP Market Growth Forecast?

The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $4.03 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for rapid cardiac diagnostics, expansion of point-of-care testing adoption, growing elderly population base, rising integration of ai-assisted diagnostic interpretation, increasing focus on preventive cardiology care. Major trends in the forecast period include increasing adoption of high-sensitivity cardiac biomarker assays, rising use of point-of-care bnp testing devices, growing integration of automated laboratory diagnostics, expansion of early heart failure screening programs, enhanced focus on rapid turnaround diagnostic testing.

Global BNP And NTproBNP Market Segmentation

1) By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide) 2) By Location Of Testing: Point Of Care Testing, Laboratory Testing 3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications Subsegments: 1) By BNP (Brain Natriuretic Peptide): BNP Testing Kits, Point-Of-Care BNP Testing Devices, Laboratory BNP Assays 2) By NT-ProBNP (N-Terminal Pro–B-Type Natriuretic Peptide): NT-ProBNP Testing Kits, Point-Of-Care NT-proBNP Testing Devices, Laboratory NT-ProBNP Assays

What Is The Driver Of The BNP And NTproBNP Market?

The rising geriatric population is expected to propel the growth of the BNP and NT-proBNP market going forward. The geriatric population is the segment of the population that consists of older adults, typically defined as individuals who are 65 or older. BNP and NT-proBNP serve as critical biomarkers in the geriatric population, aiding in the diagnosis and management of heart failure by providing valuable insights into cardiac function and helping guide appropriate treatment strategies for elderly individuals. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, globally, 1 in 6 individuals will be 60 or older by 2030 and is expected to reach 2.1 billion elderly people by 2050. Therefore, the rising geriatric population is driving the growth of the BNP and NT-proBNP market.

Key Players In The Global BNP And NTproBNP Market

Major companies operating in the bnp and ntprobnp market are Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., F Hoffman La Roche Ltd., CTK Biotech Inc., RayBiotech Life Inc., BHR Pharmaceuticals Ltd., Getein Biotech Inc., VACURE Biotechnology Co. Ltd., Bio-Techne Co., Xiamen Biotime Biotechnology Co. Ltd., Scripps Laboratories Inc., Danaher Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., LSI Medience Corporation, Shionogi & Co. Ltd., Radiometer Medical ApS, Ortho Clinical Diagnostics, Tosoh Corporation, Aidian Oy, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Becton Dickinson and Company, Acon Laboratories Inc., Response Biomedical Corp., Nanomix Inc., Cepheid Inc., Alere Inc.

Global BNP And NTproBNP Market Trends and Insights

Major companies operating in the BNP and NTproBNP market are increasing their focus on introducing rapid screening bioassays to gain a competitive edge in the market. Rapid screening bioassays refer to biological tests that efficiently assess the presence, concentration, or activity of a substance by measuring its effects on living cells or organisms, enabling quick and reliable identification or categorization of specific attributes or conditions. For instance, in October 2023, Mindray Medical International Limited, a China-based medical device company, launched two new assays that can help diagnose and manage cardiovascular diseases (CVDs). These assays are called high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). By adding these new assays to its diverse portfolio of cardiac biomarkers, Mindray has enhanced its ability to screen, stratify risk, diagnose rapidly, and monitor therapy for CVDs. Mindray collaborated with HyTest, a pioneer in cardiac biomarkers, to integrate HyTest's research and antibodies into Mindray's immunoassay platforms.

What Are Latest Mergers And Acquisitions In The BNP And NTproBNP Market?

In July 2024, Roche Holding AG, a Switzerland-based company specializing in pharmaceuticals and diagnostics, acquired LumiraDx Limited for an undisclosed amount. This acquisition aims to enhance Roche's diagnostics portfolio by integrating innovative point-of-care technology that enables rapid testing for BNP and NT-proBNP. LumiraDx Limited is a UK-based diagnostics company recognized for innovative rapid test for NT-proBNP.

Regional Outlook

Asia-Pacific was the largest region in the BNP and NTproBNP market in 2025.North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the BNP And NTproBNP Market?

The BNP and NTproBNP market includes revenues earned by companies by providing diagnostic and heart disease detection services using BNP (B-type natriuretic peptide) or NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) as biomarkers, BNP and NTproBNP assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the BNP And NTproBNP Market Report 2026?

The bnp and ntprobnp market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bnp and ntprobnp industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.